Cancer-related fatigue: The impact of skeletal muscle mass and strength in patients with advanced cancer

Journal of Cachexia, Sarcopenia and Muscle

Volumn 1, Issue 2, 2010, Pages 177-185

  Kilgour, Robert D ^a,b   Vigano, Antonio ^b   Trutschnigg, Barbara ^b   Hornby, Laura ^b   Lucar, Enriqueta ^b   Bacon, Simon L ^a   Morais, J A ^b  

^a Gina Cody School of Engineering and Computer Science   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cancer; Fatigue; Skeletal muscle mass index; Strength

Indexed keywords

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EXAMINATION; DEPRESSION; DIGESTIVE SYSTEM CANCER; DYNAMOMETRY; FEMALE; GRIP STRENGTH; HUMAN; HYPOALBUMINEMIA; ISOKINETIC EXERCISE; ISOMETRICS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; WEIGHT REDUCTION;

EID: 84856705986     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-010-0016-0     Document Type: Article

References (41)

1. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003; 362: 640-50.
2. Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, et al. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer. 2007; 15: 39-45.
3. Yennurajalingam S, Palmer J, Zhang T, Poulter V, Bruera E. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2008; 16: 1125-30.
4. Berglund G, Bolund C, Fornander T, et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer. 1991; 27: 1075-81.
5. Jager A, Sleijfer S, van der Rijt C. The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer. 2008; 44: 175-81.
6. Fearon K, Voss A, Hustead D. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006; 83: 1345-50.
7. Michalaki V, Syrigos K, Charles P, et al. Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004; 90: 2312-6.
8. Demetri G, Kris M, Wade J, Degos L, Cella D. Quality of life benefit in chemotherapy patients treated with epoeitin alpha is independent of disease response or tumor type: results from a prospective Community Oncology study. J Clin Oncol. 1998; 16: 3412-25.
9. Shafqat A, Einhorn L, Hanna N, Sledge G, Hanna A, Juliar B, et al. Screening for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol. 2005; 16: 1545-50.
10. Evans W, Morley J, Argiles J, Bales C, Baracos V, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-9.
11. Stone P, Richards M, A'Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000; 11: 561-7.
12. Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999; 79: 1479-86.
13. Winters-Stone K, Bennett J, Nail L, Schwartz A. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurse Forum. 2008; 35: 815-21.
14. Olson K, Turner A, Courneya K, Field C, Man G, Cree M, et al. Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Cancer Care. 2008; 16: 241-9.
15. Dimeo F, Stieglitz R, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer. 1999; 85: 2273-7.
16. Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E. Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol. 2008; 19: 1495-9.
17. Segal R, Reid R, Courneya K, Malone S, Parliament M, Scott C, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003; 21: 1653-9.
18. Convertino V, Bloomfield S, Greenleaf J. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc. 1997; 29: 187-90.
19. Strasser F. Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue. Curr Opin Clin Nutr Metab Care. 2008; 11: 417-21.
20. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, et al. Appendicular skeletal mass: measurement by dual photon absorptiometry. Am J Clin Nutr. 1990; 52: 214-8.
21. Innes E. Handgrip strength testing: a review of the literature. Aust Occup Ther J. 1999; 46: 120-40.
22. Trutschnigg B, Kilgour RD, Reinglas J, Rosenthall L, Hornby L, Morais JA, et al. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab. 2008; 33: 1232-9.
23. Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005; 103: 377-82.
24. Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006; 83: 1345-50.
25. Drouin JM, Valovich-McLeod TC, Shultz SJ, Gansneder BM, Perrin DH. Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol. 2004; 91: 22-9.
26. Wilcock A, Maddocks M, Lewis M, Howard P, Frisby J, Bell S, et al. Use of a Cybex NORM dynamometer to assess muscle function in patients with thoracic cancer. BMC Palliat Care. 2008; 7: 3. doi: 10. 1186/1472-684X-7-3.
27. Weber M-A, Krakowski-Roosen H, Schröder L, Kinscherf R, Krix M, Kopp-Schneider A, et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol. 2009; 48: 116-24.
28. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999; 85: 1186-96.
29. Chang YJ, Lee JS, Lee CG, Lee WS, Lee KS, Bang SM, et al. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007; 15: 891-6.
30. Yennurajalingam S, Bruera E. Fatigue and asthenia. In Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, editors. Oxford Textbook of Palliative Medicine 4th edition, Oxford; 2010.
31. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991; 7: 6-9.
32. Charlson ME, Ales KA, Pompei P, Mackenzie CR. A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373-83.
33. Zubrod CG, Sheiderman MA, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960; 11: 7-33.
34. Modlesky C, Bickel C, Slade J, Meyer RA, Cureton KJ, Dudley GA. Assessment of skeletal muscle mass in men with spinal cord injury using dual-energy X-ray absorptiometry and magnetic resonance imaging. J Appl Physiol. 2004; 96: 561-5.
35. Shih R, Wang Z, Heo M, Wang W, Heymsfield SB. Lower limb skeletal muscle mass: development of dual-energy X-ray absorptiometry prediction model. J Appl Physiol. 2000; 89: 1380-6.
36. Lynch NA, Metter EJ, Lindle RS, Fozard JL, Tobin JD, Roy TA, et al. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol. 1999; 86: 188-94.
37. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the Health, Aging and Body Composition Study cohort. J Gerontol Med Sci. 2006; 61A: 72-7.
38. Goodpaster B, Carlson C, Visser M, Kelley DE, Scherzinger A, Harris TB, et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol. 2001; 90: 2157-65.
39. Davis M, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010; 8: 164-74.
40. von Haehling S, Morley JE, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010. doi: 10. 1007/s13539-010-0003-5.
41. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147: 755-63.